Learn more >
The Informed Medical Decisions Foundation, a division of Healthwise, has been working to advance evidence-based shared decision making since 1989. Our research and advocacy efforts help people make better health decisions.
Neither clinicians nor patients like the idea of “one-size-fits-all” health care. Recently, the concept of “personalized medicine,” also called “precision medicine,” has been popularized. Personalized medicine involves tailoring the diagnosis and treatment to the risks of disease and likelihood of response to treatments for individuals, rather than populations.
Shared decision making (SDM) continues to gain great momentum through the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and Meaningful Use (MU), but a proposed change to the MU requirement for Stage 3 threatens that progress.
In April 2015, President Obama signed into law the Medicare Access and CHIP Reauthorization Act of 2015, simply called MACRA. Unlike the Affordable Care Act (“ObamaCare”), the MACRA bill had rare, overwhelming bipartisan support, with a final vote of 392-37 in the House and 92-8 in the Senate.